Submitted by reuters8361 in business
The U.S. Food and Drug Administration said on Tuesday it authorized an updated version of Novavax's <a href="https://www.reuters.com/markets/companies/NVAX.O" target="_blank">(NVAX.O)</a> COVID-19 vaccine for emergency use in individuals aged 12 years and old…